Engineered Lactococcus lactis secreting a glucagon-like peptide-1-inducing protein P9 for amelioration of obesity in mice
3 Biotech · 2025-09 · 15 (9)
DOI: 10.1007/s13205-025-04465-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift 3 Biotech, online erschienen am 15.08.2025. Verfasst von Wenxuan Di und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Nutritional Engineering, China Agricultural University, No.17 Tsinghua East Road, Hai Dian District, Beijing, 100083 Peop…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Beijing Technology & Business University.
Abstract (Originalsprache)
This study investigated the anti-obesity potential of Lactococcus lactis engineered to constitutively secrete P9 (Amuc_1631), a protein from Akkermansia muciniphila. Our findings show that the engineered strain L. lactis P11P9 effectively secretes P9 and significantly increases GLP-1 production in NCI-H716 enteroendocrine cells, with a 2.65-fold rise compared to controls. In high-fat diet (HFD)-induced obese mice, oral administration of L. lactis P11P9 resulted in reduced weight gain, decreased food intake, and attenuation of adipocyte hypertrophy. ELISA analysis of serum samples indicated that L. lactis P11P9 treatment elevated circulating GLP-1 levels. RT-qPCR analysis further revealed increased expression of GLP-1 synthesis-related genes (e.g., GCG and PCSK1) in intestinal tissues. In addition, transcription of thermogenesis-associated genes such as UCP1 and PGC-1α was upregulated in adipose tissue. Taken together, this study suggests that engineered L. lactis P11P9 helps reduce obesity by increasing GLP-1 secretion and stimulating thermogenesis, providing a promising strategy for obesity treatment. Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-025-04465-5.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Food Science and Nutritional Engineering, China Agricultural University, No.17 Tsinghua East Road, Hai Dian District, Beijing, 100083 People's Republic of China.
- Research Center for Probiotics, China Agricultural University, Sanhe, 065200 China.
- Beijing Diabetes Institute, Beijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730 China.
- Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, China.
- Food Laboratory of Zhongyuan, Luohe, 462300 Henan China.
ORCID-Profile: Zhengyuan Zhai
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Beijing Technology & Business University
Zitieren
APA
Di, W., Bai, X., Tian, S., Zhao, L., Cao, X., Hao, Y., & Zhai, Z. (2025). Engineered Lactococcus lactis secreting a glucagon-like peptide-1-inducing protein P9 for amelioration of obesity in mice. 3 Biotech, 15(9). https://doi.org/10.1007/s13205-025-04465-5
Vancouver
Di W, Bai X, Tian S, Zhao L, Cao X, Hao Y, et al. Engineered Lactococcus lactis secreting a glucagon-like peptide-1-inducing protein P9 for amelioration of obesity in mice. 3 Biotech. 2025;15(9). doi:10.1007/s13205-025-04465-5
BibTeX
@article{Di2025,
author = {Di, Wenxuan and Bai, Xiaoyue and Tian, Shuangrui and Zhao, Liang and Cao, Xi and Hao, Yanling and Zhai, Zhengyuan},
title = {Engineered Lactococcus lactis secreting a glucagon-like peptide-1-inducing protein P9 for amelioration of obesity in mice},
journal = {3 Biotech},
year = {2025},
volume = {15},
number = {9},
doi = {10.1007/s13205-025-04465-5}
}
EUVIMED